{"id":1068284,"date":"2022-10-03T01:51:03","date_gmt":"2022-10-03T05:51:03","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/myovant-sciences-special-committee-of-board-confirms-receipt-of-preliminary-non-binding-proposal-from-sumitovant-biopharma-and-sumitomo-pharma-to\/"},"modified":"2024-08-18T11:45:21","modified_gmt":"2024-08-18T15:45:21","slug":"myovant-sciences-special-committee-of-board-confirms-receipt-of-preliminary-non-binding-proposal-from-sumitovant-biopharma-and-sumitomo-pharma-to","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/myovant-sciences-special-committee-of-board-confirms-receipt-of-preliminary-non-binding-proposal-from-sumitovant-biopharma-and-sumitomo-pharma-to.php","title":{"rendered":"Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to&#8230;"},"content":{"rendered":"<p><![CDATA[BASEL, Switzerland, Oct.  02, 2022  (GLOBE NEWSWIRE) -- Myovant Sciences Ltd. (NYSE: MYOV) (the \u201cCompany\u201d) confirmed today that it has received a preliminary, non-binding proposal (the \u201cProposal\u201d) from Sumitovant Biopharma Ltd. (\u201cSumitovant\u201d) and Sumitomo Pharma Co., Ltd. (collectively with Sumitovant, \u201cSumitomo\u201d) to acquire the remaining shares of the Company that Sumitovant does not currently hold, for a price of $22.75 per share in cash. Sumitovant currently holds approximately 52% of the outstanding shares of the Company.]]><\/p>\n<p>See more here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/10\/02\/2526430\/0\/en\/Myovant-Sciences-Special-Committee-of-Board-Confirms-Receipt-of-Preliminary-Non-binding-Proposal-from-Sumitovant-Biopharma-and-Sumitomo-Pharma-to-Acquire-Remaining-Shares.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to...\">Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See more here: Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/myovant-sciences-special-committee-of-board-confirms-receipt-of-preliminary-non-binding-proposal-from-sumitovant-biopharma-and-sumitomo-pharma-to.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068284","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068284"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068284"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068284\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}